Data / Public companies / Germany
Germany: 11 companies that file annual reports with the SEC
11 companies that file annual reports with the SEC have a business address in Germany, in the SEC Financial Statement Data Sets filed through September 30, 2026. 4 report revenue, a combined $9.3 million. 50.0% of the 4 that report net income show a profit. The largest by revenue is Anbio Biotechnology ($8.6 million).
SpecStream is the live web data engine for teams and agents. It reads the annual reports that companies file with the SEC, and this page is that reading. Ask for the companies of an industry, state or city with their website, number of employees and funding added from the web, and each new annual report arrives in your sheet, CRM, Slack or agent as the SEC posts it.
- 11Companies with an annual report in the data
- 4Companies that report revenue
- $9.3 millionCombined revenue
- $316,244Median revenue
- 2 of 4 (50.0%)Reported a net profit
- $35.8 millionCombined total assets
- 3Large accelerated filers
- August 27, 2026Newest annual report filed
Largest by revenue
Latest fiscal year, from each company's annual report. Each name links to the company's page.
| Company | Business address | Revenue | Net income | Total assets | Revenue change |
|---|---|---|---|---|---|
| Anbio Biotechnology | Frankfurt Am Main, Germany | $8.6 million | $6.4 million | $30.2 million | 5.6% |
| Mainz Biomed N.V. | Mainz, Germany | $537,080 | $-16,210,718 | $5.3 million | -39.9% |
| Stagewise Strategies Corp. | Berlin, Germany | $95,409 | $-74,758 | $164,867 | 959.3% |
| Tech Tonic Group Corp. | Krefeld, Germany | $66,920 | $1,148 | $63,414 | -27.3% |
Industries with the most companies
By the SEC's Standard Industrial Classification (SIC) code of the company.
| Industry | Companies | Share | Combined revenue |
|---|---|---|---|
| Pharmaceutical preparations | 2 | 18.2% | $537,080 |
| Biological products, (no diagnostic substances) | 2 | 18.2% | $0 |
| Computer processing and data preparation | 2 | 18.2% | $95,409 |
| In vitro and in vivo diagnostic substances | 1 | 9.1% | $8.6 million |
| Semiconductors and related devices | 1 | 9.1% | $0 |
| Computer programming services | 1 | 9.1% | $66,920 |
| Prepackaged software | 1 | 9.1% | $0 |
| Misc health and allied services, NEC | 1 | 9.1% | $0 |
Newest annual reports
By the date the company filed its latest annual report with the SEC.
| Company | Filed | Fiscal year ended | Form | Revenue |
|---|---|---|---|---|
| Tech Tonic Group Corp. | August 27, 2026 | June 30, 2026 | 10-K | $66,920 |
| Anbio Biotechnology | April 7, 2026 | December 31, 2025 | 20-F | $8.6 million |
| Sono Group N.V. | April 1, 2026 | December 31, 2025 | 10-K | Not listed |
| Mainz Biomed N.V. | March 31, 2026 | December 31, 2025 | 10-K | $537,080 |
| Inflarx N.V. | March 20, 2026 | December 31, 2025 | 20-F | Not listed |
| Biontech Se | March 10, 2026 | December 31, 2025 | 20-F | Not listed |
| Immatics N.V. | March 5, 2026 | December 31, 2025 | 20-F | Not listed |
| Trivago N.V. | February 26, 2026 | December 31, 2025 | 20-F | Not listed |
| Sap Se | February 26, 2026 | December 31, 2025 | 20-F | Not listed |
| Fresenius Medical Care AG | February 24, 2026 | December 31, 2025 | 20-F | Not listed |
| Stagewise Strategies Corp. | December 16, 2025 | September 30, 2025 | 10-K | $95,409 |
Filer category
The SEC's size class for the company when it filed.
| Category | Companies | Share |
|---|---|---|
| Non-accelerated filer | 6 | 54.5% |
| Large accelerated filer | 3 | 27.3% |
| Accelerated filer | 2 | 18.2% |
Updated September 30, 2026. Read from SEC Financial Statement Data Sets (sec.gov). Public data from the US Securities and Exchange Commission. Companies are the registrants whose latest annual report (form 10-K, 20-F or 40-F) is in the SEC Financial Statement Data Sets for 2025 Q3 to 2026 Q3, filed through September 30, 2026. Figures are for the whole fiscal year of that report, in US dollars, as the company filed them in XBRL: SpecStream does not adjust them. The SEC does not guarantee the data sets, and they do not replace the filings. Revenue is the revenue tag the company used; banks and funds often use none. Combined totals add each company once and can include a parent and its subsidiary that both file. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.